This inventor holds 18 USPTO granted patents and 3 published patent applications and 12 EPO patents, primarily in Antiviral Peptides. Top assignees: Centro De Ingenieria Genetica Y Biotecnologia, Centro De Ingenieria Genetica Y Biotechnologia. Active years: 2006-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Playa, CU (2008)
- La Habana, CU (2015)
- Ciudad de la Habana, CU (2006 - 2016)
- Playa la Habana, CU (2018)
- Havana, CU (2013 - 2019)
Company Filing History:
16 out of 83 
2 out of 15 Years Active: 2006-2025
Areas of Expertise:
Title: The Innovations of Osvaldo Reyes Acosta: Advancing HIV and Dengue Virus Research
Introduction:
In the world of medical innovation, Osvaldo Reyes Acosta has made significant contributions, especially in the field of inhibiting HIV replication and combating Dengue virus infections. With 17 patents to his name, Reyes Acosta's groundbreaking research and inventions have the potential to revolutionize the way we approach these diseases. Let's delve deeper into his latest patents and notable collaborations.
HIV Replication Inhibition Method:
Reyes Acosta's patent titled "Method for inhibiting HIV replication in mammal and human cells" presents a unique approach to curbing the replication of the human immunodeficiency virus (HIV). His invention focuses on negatively modulating or altering the cytoskeleton, particularly the proteins vimentin and keratin-10. By intervening in the structure of these proteins, the replication of the virus can be effectively inhibited in human cells. Additionally, the patent explores the use of various agents such as peptides, interfering RNA, and lipidic compounds to achieve this negative modulation or alteration of the cytoskeleton, offering potential avenues for preventing or treating HIV infections.
Antiviral Properties Against Dengue Virus:
Another notable invention by Reyes Acosta is the patent titled "Beta hairpin peptides having antiviral properties against Dengue virus." It introduces structurally constrained synthetic peptides that are specifically optimized for forming a beta hairpin structure. These peptides exhibit the ability to inhibit or attenuate Dengue virus (DENV) infections. Reyes Acosta's research breakthrough also includes the development of pharmaceutical compositions containing these synthetic peptides, which hold promise for both prevention and treatment of DENV-caused infections. The patent further details a method for treating infections caused by the Dengue virus.
Professional Experience and Collaborations:
Reyes Acosta has worked with renowned institutions such as the Centro de Ingeniería Genética y Biotecnología (Center for Genetic Engineering and Biotechnology), known as CIGB, in Cuba. His affiliation with this esteemed organization highlights his consistent presence in the field of biotechnology and genetic engineering.
Throughout his career, Reyes Acosta has collaborated with several notable individuals. Among his coworkers, Glay Chinea Santiago and Hilda Elisa Garay Perez deserve special mention for their contributions to the various projects associated with Osvaldo Reyes Acosta's patents.
Conclusion:
Osvaldo Reyes Acosta's contributions to the field of medical and molecular research are commendable. His patents, such as the method to inhibit HIV replication and the development of peptides with antiviral properties against Dengue virus, showcase his dedication to advancing healthcare and tackling critical global health challenges. As we look to the future, it is innovators like Reyes Acosta who inspire us with their significant contributions to the field of patents and inventions.
For more information about Osvaldo Reyes Acosta and other prominent inventors, companies, and patents, visit our website idiyas.com.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile